Literature DB >> 27966076

The Level of Testosterone, Vitamin D, and Irregular Menstruation More Important than Omega-3 in Non-Symptomatic Women Will Define the Fate of Multiple Scleroses in Future.

Shima Tavakol1,2, Sahar Shakibapour3, Sepideh Arbabi Bidgoli4,5.   

Abstract

Multiple sclerosis is one of the most salient degenerative disorders of CNS with dysregulated immune process that resulted in axonal damage and demyelination. In the present investigation, the serum level of testosterone was assessed in women who were struggling with multiple sclerosis (MS). Also, the level of omega-3, vitamin D, and the irregular menstruation in women 5 years before the onset MS symptoms were surveyed. Although the levels of omega-3 and vitamin D in women MS patients were non-significant and significantly less than the healthy ones, they were significantly less in the whole population of MS patients. However, the MS patients more experienced more irregular menstruation some years before the onset of MS with the low level of testosterone. Based on the presented findings, it might be said that the vitamin D intake has significant protective role in women and men MS patients unlike the omega-3 that had significant protective role just in men. However, vitamin D metabolism encoding genes of CYP27B1 and CYP24A1 and predicting MS risk gene of HLA-DRB1*15:01 define its fate as well. Besides, vitamin D intake, through the proliferation decrement of pro-inflammatory cells, decreases of pro-inflammatory markers (IL-6, TNF-α, INF-γ) and auto-immune pathways have potential role in recovery of irregular menstruation in women with the low level of testosterone as a red warning factor of MS development. The low level of testosterone and vitamin D consumption increase the neural damage and pro-inflammatory pathways in MS patients, and the difference among the investigations is related to the long-standing history of MS that influences severity of damage to the neural cells and biomolecules and complicate its recovery.

Entities:  

Keywords:  Genetic; Inflammatory cells; Multiple sclerosis in women; Omega-3; Testosterone; Vitamin D

Mesh:

Substances:

Year:  2016        PMID: 27966076     DOI: 10.1007/s12035-016-0325-1

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  73 in total

1.  Sex hormones modulate inflammatory mediators produced by macrophages.

Authors:  P D'Agostino; S Milano; C Barbera; G Di Bella; M La Rosa; V Ferlazzo; R Farruggio; D M Miceli; M Miele; L Castagnetta; E Cillari
Journal:  Ann N Y Acad Sci       Date:  1999-06-22       Impact factor: 5.691

2.  Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.

Authors:  M Dalal; S Kim; R R Voskuhl
Journal:  J Immunol       Date:  1997-07-01       Impact factor: 5.422

3.  Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis.

Authors:  Laurie Beth J Morales; Kyi Kyi Loo; Hong-Biao Liu; Cory Peterson; Seema Tiwari-Woodruff; Rhonda R Voskuhl
Journal:  J Neurosci       Date:  2006-06-21       Impact factor: 6.167

Review 4.  Estrogen and testosterone therapies in multiple sclerosis.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

5.  The role of aromatization in testosterone supplementation: effects on cognition in older men.

Authors:  M M Cherrier; A M Matsumoto; J K Amory; S Ahmed; W Bremner; E R Peskind; M A Raskind; M Johnson; S Craft
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

6.  Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells.

Authors:  B F Bebo; J C Schuster; A A Vandenbark; H Offner
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

Review 7.  Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis.

Authors:  Caren Ramien; Aline Taenzer; Andreea Lupu; Nina Heckmann; Jan Broder Engler; Kostas Patas; Manuel A Friese; Stefan M Gold
Journal:  Neurosci Biobehav Rev       Date:  2016-01-08       Impact factor: 8.989

8.  Role of vitamin D deficiency and lack of sun exposure in the incidence of premenopausal breast cancer: a case control study in Sabzevar, Iran.

Authors:  Sepideh Arbabi Bidgoli; Hamid Azarshab
Journal:  Asian Pac J Cancer Prev       Date:  2014

9.  Testosterone treatment in multiple sclerosis: a pilot study.

Authors:  Nancy L Sicotte; Barbara S Giesser; Vinita Tandon; Ricki Klutch; Barbara Steiner; Ann E Drain; David W Shattuck; Laura Hull; He-Jing Wang; Robert M Elashoff; Ronald S Swerdloff; Rhonda R Voskuhl
Journal:  Arch Neurol       Date:  2007-05

10.  Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

Authors:  Florian Kurth; Eileen Luders; Nancy L Sicotte; Christian Gaser; Barbara S Giesser; Ronald S Swerdloff; Michael J Montag; Rhonda R Voskuhl; Allan Mackenzie-Graham
Journal:  Neuroimage Clin       Date:  2014-03-06       Impact factor: 4.881

View more
  2 in total

1.  A combination therapy of nanoethosomal piroxicam formulation along with iontophoresis as an anti-inflammatory transdermal delivery system for wound healing.

Authors:  Mostafa Kazemi; Reza Mombeiny; Shima Tavakol; Peyman Keyhanvar; Kazem Mousavizadeh
Journal:  Int Wound J       Date:  2019-08-08       Impact factor: 3.315

Review 2.  Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles.

Authors:  Reza Mohammadinejad; Mohammad Amin Moosavi; Shima Tavakol; Deniz Özkan Vardar; Asieh Hosseini; Marveh Rahmati; Luciana Dini; Salik Hussain; Ali Mandegary; Daniel J Klionsky
Journal:  Autophagy       Date:  2018-09-13       Impact factor: 16.016

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.